Safety, Tolerability and Symptom Outcomes Associated with l-Carnitine Supplementation in Patients with Cancer, Fatigue, and Carnitine Deficiency: A Phase I/II Study

Journal of Pain and Symptom Management

Volumn 32, Issue 6, 2006, Pages 551-559

  Cruciani, Ricardo A ^a   Dvorkin, Ella ^a   Homel, Peter ^a   Malamud, Stephen ^a   Culliney, Bruce ^a   Lapin, Jeanne ^a   Portenoy, Russell K ^a   Esteban Cruciani, Nora ^a  

^a BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

cancer related fatigue; l carnitine deficiency; l carnitine supplementation

Indexed keywords

CARNITINE;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER; CARNITINE DEFICIENCY; CLINICAL TRIAL; COLON CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EPWORTH SLEEPINESS SCALE; FATIGUE; FEMALE; HEAD AND NECK CANCER; HUMAN; KARNOFSKY PERFORMANCE STATUS; LEUKEMIA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RECTUM CANCER; SCORING SYSTEM; SEX RATIO; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; CARNITINE; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; TREATMENT OUTCOME; VITAMIN B DEFICIENCY;

EID: 33845349279     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.09.001     Document Type: Article

References (20)

1. Portenoy R.K., and Itri L.M. Cancer-related fatigue: guidelines for evaluation and management. Oncologist 4 (1999) 1-10
2. Portenoy R.K., and Miaskowski C. Assessment and management of cancer-related fatigue. In: Berger A., Portenoy R.K., and Weissman D.E. (Eds). Principles and practices of supportive oncology (1998), Lippincott-Raven Publishers, Philadelphia, PA 109-118
3. Vogelzang N., Breitbart W., Cella D., et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tri-part assessment survey. Semin Hematol 34 Suppl 2 (1997) 4-12
4. Cassileth B.R., Lusk E.J., Bodenheimer B.J., et al. Chemotherapeutic toxicity-the relationship between patients' pretreatment expectations and post-treatment results. Am J Clin Oncol 8 (1985) 419-425
5. Cruciani R.A., Dvorkin E., Homel P., et al. L-carnitine supplementation in cancer patients with fatigue and carnitine deficiency. [abstract]. ASCO Annual Meeting Proceedings (Post-Meeting Edition). J Clin Oncol 22 14S (2004) 8025
6. Cruciani RA, Dvorkin E, Homel P, et al. L-carnitine supplementation for the treatment of fatigue in cancer patients [abstract]. Proceedings of the Society for Integrative Oncology First International Conference, New York, November 2004.
7. Cruciani RA, Dvorkin E, Homel P, et al. Effect of L-carnitine supplementation in cancer patients with fatigue: a preliminary analysis. Proceedings of Complementary Therapies and Cancer Care: a research symposium, London, June 2004.
8. Winter S.C., Szabo Aczel S., Curry C.J., et al. Plasma carnitine deficiency. Clinical observations in 51 patients. Am J Dis Child 141 (1987) 660-665
9. Dodson W.L., Sachan D.S., Krauss S., and Hanna W. Alterations of serum and urinary carnitine profiles in cancer patients: hypothesis of possible significance. J Am Coll Nutr 8 2 (1989) 133-142
10. Esteban-Cruciani N.V. Severe carnitine deficiency in children with AIDS: improved functional activity status after supplementation. [abstract]. Pediatr Res 49 4 (2001) 254
11. Esteban-Cruciani N.V., Bestak M., Walsh C., et al. High prevalence of carnitine deficiency in children with chronic illness. [abstract]. Pediatr Res 51 4 (2002) 218
12. Pons R., and De Vivo D.C. Primary and secondary carnitine deficiency syndromes. J Child Neurol 10 Suppl 2 (1995) 2S8-2S24
13. De Vivo D.C., and Tein I. Primary and secondary disorders of carnitine metabolism. Int Pediatr 5 2 (1990) 134-141
14. Cruciani R.A., Dvorkin E., Homel P., et al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann NY Acad Sci 1033 (2004) 168-176
15. Mendoza T.R., Wang X.S., Cleeland C.S., et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 85 (1999) 1186-1196
16. Radloff L.S. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1 3 (1977) 385-401
17. Johns M.W. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep 14 (1991) 540-545
18. Yates J.W., Chalmer B., and McKegney F.P. Evaluation of patients with advanced cancer using the Karnofsky Performance Status. Cancer 40 (1980) 2220-2224
19. Graziano F., Bisonni R., Catalano V., et al. Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anemic cancer patients. Br J Cancer 86 (2002) 1854-1857
20. Gramignano G., Lusso M.R., Madeddu C., et al. Efficacy of L-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy. Nutrition 22 2 (2006) 136-145